Refusal to reimburse medicinal products in individual cases under Article 71a et seq. KVV
A marketing authorization holder contacted us due to a dispute with a health insurance company in connection with the reimbursement of medicinal products in individual cases based on Article 71a et seq. of the Health Insurance Ordinance (KVV).
Experimental therapy
Swiss doctors have enquired with an international pharmaceutical company about the availability of a drug not approved in Switzerland for the treatment of a fatal disease as part of an experimental trial.